Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

EPA:CROS - Euronext Paris - Matif - FR0000050395 - Common Stock - Currency: EUR

10.8  +1.2 (+12.5%)

Fundamental Rating

4

Taking everything into account, CROS scores 4 out of 10 in our fundamental rating. CROS was compared to 73 industry peers in the Real Estate Management & Development industry. CROS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CROS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CROS had positive earnings in the past year.
CROS had a positive operating cash flow in the past year.
CROS had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CROS reported negative operating cash flow in multiple years.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.47%, CROS is in the better half of the industry, outperforming 65.75% of the companies in the same industry.
CROS's Return On Equity of 1.86% is in line compared to the rest of the industry. CROS outperforms 58.90% of its industry peers.
CROS has a Return On Invested Capital (0.59%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CROS is below the industry average of 3.86%.
The last Return On Invested Capital (0.59%) for CROS is above the 3 year average (0.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.47%
ROE 1.86%
ROIC 0.59%
ROA(3y)3.96%
ROA(5y)5.5%
ROE(3y)5.07%
ROE(5y)7.37%
ROIC(3y)0.44%
ROIC(5y)0.63%
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 6 8 10

1.3 Margins

CROS has a better Profit Margin (150.55%) than 97.26% of its industry peers.
The Operating Margin of CROS (86.10%) is better than 97.26% of its industry peers.
In the last couple of years the Operating Margin of CROS has declined.
The Gross Margin of CROS (81.23%) is better than 78.08% of its industry peers.
In the last couple of years the Gross Margin of CROS has grown nicely.
Industry RankSector Rank
OM 86.1%
PM (TTM) 150.55%
GM 81.23%
OM growth 3Y-0.97%
OM growth 5Y-16.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y3.08%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CROS is destroying value.
CROS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CROS has about the same amount of shares outstanding.
Compared to 1 year ago, CROS has an improved debt to assets ratio.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.21 indicates that CROS is not in any danger for bankruptcy at the moment.
CROS's Altman-Z score of 4.21 is amongst the best of the industry. CROS outperforms 94.52% of its industry peers.
The Debt to FCF ratio of CROS is 2.27, which is a good value as it means it would take CROS, 2.27 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.27, CROS belongs to the top of the industry, outperforming 95.89% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that CROS is not too dependend on debt financing.
CROS has a better Debt to Equity ratio (0.04) than 82.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.27
Altman-Z 4.21
ROIC/WACC0.08
WACC7.67%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.28 indicates that CROS should not have too much problems paying its short term obligations.
CROS's Current ratio of 1.28 is in line compared to the rest of the industry. CROS outperforms 46.58% of its industry peers.
CROS has a Quick Ratio of 1.28. This is a normal value and indicates that CROS is financially healthy and should not expect problems in meeting its short term obligations.
CROS has a better Quick ratio (1.28) than 64.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 226.76% over the past year.
Looking at the last year, CROS shows a decrease in Revenue. The Revenue has decreased by -6.15% in the last year.
CROS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.96% yearly.
EPS 1Y (TTM)226.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.84%
Revenue 1Y (TTM)-6.15%
Revenue growth 3Y-12.91%
Revenue growth 5Y-2.96%
Sales Q2Q%0.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 77.14 indicates a quite expensive valuation of CROS.
The rest of the industry has a similar Price/Earnings ratio as CROS.
CROS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.31.
Industry RankSector Rank
PE 77.14
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CROS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 61.99
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The decent profitability rating of CROS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CROS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CROSSWOOD

EPA:CROS (6/11/2025, 7:00:00 PM)

10.8

+1.2 (+12.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners63.64%
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap114.80M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)125.18%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 77.14
Fwd PE N/A
P/S 114.01
P/FCF 61.99
P/OCF 44.67
P/B 1.41
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)0.14
EY1.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.17
FCFY1.61%
OCF(TTM)0.24
OCFY2.24%
SpS0.09
BVpS7.66
TBVpS7.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 1.86%
ROCE 0.86%
ROIC 0.59%
ROICexc 0.6%
ROICexgc 0.6%
OM 86.1%
PM (TTM) 150.55%
GM 81.23%
FCFM 183.91%
ROA(3y)3.96%
ROA(5y)5.5%
ROE(3y)5.07%
ROE(5y)7.37%
ROIC(3y)0.44%
ROIC(5y)0.63%
ROICexc(3y)0.45%
ROICexc(5y)0.65%
ROICexgc(3y)0.45%
ROICexgc(5y)0.65%
ROCE(3y)0.65%
ROCE(5y)0.93%
ROICexcg growth 3Y-15.8%
ROICexcg growth 5Y-23.21%
ROICexc growth 3Y-15.79%
ROICexc growth 5Y-23.21%
OM growth 3Y-0.97%
OM growth 5Y-16.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y3.08%
F-Score7
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 13.55
Cash Conversion N/A
Profit Quality 122.16%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 4.21
F-Score7
WACC7.67%
ROIC/WACC0.08
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)41.17%
Cap/Sales(5y)29.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)226.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.15%
Revenue growth 3Y-12.91%
Revenue growth 5Y-2.96%
Sales Q2Q%0.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y144.23%
EBIT growth 3Y-13.76%
EBIT growth 5Y-18.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y240.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y549.3%
OCF growth 3Y-22.79%
OCF growth 5Y-21.99%